Waterloo Capital’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
Waterloo Capital's LUCD Position: Q3 2026 in Review
Waterloo Capital opened a new position in Lucid Diagnostics (LUCD) in Q3 2026: 11,484 shares worth $8.62K. The stake represents ﹤0.01% of the portfolio and ranks #666 among its holdings.
115 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.
- Waterloo Capital held 11,484 shares of Lucid Diagnostics worth $8.62K as of Q3 2026.
- Lucid Diagnostics was a new Waterloo Capital position in Q3 2026.
- Lucid Diagnostics made up ﹤0.01% of Waterloo Capital's portfolio in Q3 2026, its #666 holding.
- 115 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.
Based on Waterloo Capital's 13F filing for Q3 2026, filed 16 Nov 2026.